BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
730
Frequently Asked Questions
What is Market Cap of BridgeBio Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BridgeBio Pharma Inc market cap is $9.57B.
What is the 52-week high for BridgeBio Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BridgeBio Pharma Inc 52 week high is $54.60 as of September 28, 2025.
What is the 52-week low for BridgeBio Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BridgeBio Pharma Inc 52 week low is $21.72 as of September 28, 2025.
What is BridgeBio Pharma Inc stock price today?
BridgeBio Pharma Inc stock price today is $50.05.
What was BridgeBio Pharma Inc stock price yesterday?
BridgeBio Pharma Inc stock price yesterday was $49.00.
What is the PE ratio of BridgeBio Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BridgeBio Pharma Inc’s P/E ratio is -12.23.
What is the Price-to-Book ratio of BridgeBio Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BridgeBio Pharma Inc P/B ratio is -5.3515.
What is the 50-day moving average of BridgeBio Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BridgeBio Pharma Inc 50-day moving average is $49.48.